FDA Investigator Dustin K Hampton
Dustin K Hampton has conducted inspections on 27 sites in 1 countries as of 16 May 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
27
Last Inspection Date:
16 May 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Dustin K Hampton:
Adree N Anderson,
April K Hill,
Bei Y He,
Bonnie E Pierson,
Brent T Hall,
Brian R Cronenwett,
Candace S Tucker,
Clifford F Long,
Cody D Rickman,
Cynthia M Goudeau,
Dana D Carter, SR DDS,
Danial S Hutchison,
Darrah,
David J Eide,
Dawn C Olenjack,
Derrionna M Epps,
Edward E Lockwood (EEL),
Eric C Fox,
Eric C Nielsen,
Eric M Padgett,
Erika V Butler,
Esther A Ofori,
Fred K Kelly,
Georgia A Layloff,
Gloria J Champagne,
Heath W Cartwright,
James D Planchon,
James I Giefer,
James P Mcreavey,
Janice A Hawkins,
Janna C Hutchinson,
Jeffery A Hangartner,
Jeffery L Sumter,
Jennifer Cahill,
Jill J Tillman,
John A Iwen,
Johnson,
Kamara Mo,
Karen C Daugherty,
Karen M Montgomery (KMM),
Katherine M Taylor,
Kathleen B Swat,
Kelly D Sheppard,
LCDR Matthew J Morrison,
Linda F Murphy,
Linhart,
Logan T Williams,
Marion D Wimberly, Jr,
Mary K Concannon,
Mary L Schuckmann,
Matthew A Walburger,
Matthew H Hunt,
Matthew M Schuckmann,
Matthew Schuckman,
Megan M Jekel,
Michael A Blaine,
Michael A Feingold,
Michael C Zubelewicz,
Michele L Obert,
Michele Perry Williams,
Michelle C Webb,
Monica E Murie,
Nicole J Conklin,
Pamela L Velez Vega,
Philip J Boston,
Richard L Rutherford,
Robert J Ham,
Robert J Nesselhauf,
Rodney D Combs,
Samuel K Gibbons, Jr,
Shafiq S Ahadi,
Shanna R Haden,
Sondra L Phillips,
Sri Ramakrishnaiah Yellela, PhD,
Srinivas R Chennamaneni, PhD,
Steven D Kehoe,
Steven W Brown,
Tara L Greene,
Tara L King,
Thuy T Nguyen, LCDR,
Valeria A Moore,
Veronica Fuentes, MS,
Victoria P Quadrini,
Vikas Moolchandani,
Virginia Phillips,
Walsworth,
William C Corley,
Xiaohan Cai, PhD,
Yiyue Zhang (nmi), PhD
Dustin K Hampton's Documents
Publish Date | Document Type | Title |
---|---|---|
September, 2015 | FDA 483 | Pharma Medica Research Inc. - Form 483, 2015-09-29 |
November, 2015 | FDA 483 | AssayPro - Form 483, 2015-11-05 |
June, 2016 | FDA 483 | Penner Mfg Inc - Form 483, 2016-06-21 |
June, 2016 | EIR | Bausch & Lomb Inc - EIR, 2016-06-10 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more